Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-016380
Filing Date
2025-02-07
Accepted
2025-02-07 16:41:27
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3317
  Complete submission text file 0000950170-25-016380.txt   4805
Mailing Address C/O PENINSULA PHARMACEUTICALS, INC. 1751 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address
Podlesak Dennis (Reporting) CIK: 0001314595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37708 | Film No.: 25602511

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)